Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost
Poolbeg Pharma (LON:POLB, OTCQB: POLBF) has announced that it has signed a Clinical Trial Agreement with the Centre for Human Drug Research (CHDR) in the Netherlands for the completion of a bacterial
Poolbeg Pharma plc (LON:POLB), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that trading in the Company’s Ordinary Shares of nominal value of
Infectious disease specialist Poolbeg Pharma has signed a deal with artificial intelligence company CytoReason to provide analysis of data from human challenge studies on influenza. The project, which is due to commence
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost
Poolbeg Pharma plc (LON:POLB) a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that its Annual Report and Accounts for the period ended 31st December 2021,
US giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV Poolbeg Pharma, the infectious disease pharmaceutical company, has signed a
Poolbeg Pharma plc (LON:POLB) has announced its audited results for the period ended 31 December 2021. These results follow the Company’s spin-out from Open Orphan plc and the subsequent listing on the AIM
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost
Poolbeg Pharma plc (LON:POLB) a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, will announce its results for the period ended 31 December 2021 on Thursday 3 March
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
